There's a funny old saying - "The operation was a success but the patient's dead".
It's funny because we know that survival is always the primary concern.
Fact is - there isn't a treatment that comes close to Rexlemestrocel's ability to reduce CHF mortality rates AND Ischaemic Heart Disease is the greatest case of death on the planet ( https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death )
I don't know...does anyone think Big Pharma might find this interesting?
There's a funny old saying - "The operation was a success but...
-
- There are more pages in this discussion • 365 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |